发明名称 |
INHIBITORS OF ADAMTS4 OR ADAMTS5 FOR USE IN PREVENTING OR TREATING CARDIAC REMODELING AND CHRONIC HEART FAILURE |
摘要 |
The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or preventing heart failure in a subject. In particular, the present invention provides an inhibitor of ADAMTS4 or ADAMTS5 for use in treating or preventing cardiac remodeling or chronic heart failure in a subject with cardiac remodeling or with chronic heart failure, or with a condition that may lead to cardiac remodeling and/or chronic heart failure. Also provided is a method of treating or preventing cardiac remodeling or treating or preventing heart failure which method comprises administering to a subject in need thereof a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase. Also provided is the use of an inhibitor of an ADAMTS proteoglycanase in the manufacture of a medicament for treating or preventing cardiac remodeling or treating or preventing heart failure. |
申请公布号 |
US2016158271(A1) |
申请公布日期 |
2016.06.09 |
申请号 |
US201414903624 |
申请日期 |
2014.07.09 |
申请人 |
UNIVERSITETET I OSLO |
发明人 |
VISTNES Maria;CHRISTENSEN Geir;ARONSEN Magnus;LUNDE Ida Gjervold;SJAASTAD Ivar;CARLSON Cathrine Rein |
分类号 |
A61K31/737;A61K31/453 |
主分类号 |
A61K31/737 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating or preventing cardiac remodeling or chronic heart failure in a subject comprising administering a therapeutically effective amount of an inhibitor of ADAMTS4 or ADAMTS5 to a subject having cardiac remodeling or chronic heart failure, or a subject having a condition that may lead to cardiac remodeling and/or chronic heart failure. |
地址 |
Oslo NO |